Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 26 October 2023 31 October 2024 31 October 2024 15239466 Dr Amy-Leigh Merritt iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15239466 2023-10-25 15239466 2024-10-31 15239466 2023-10-26 2024-10-31 15239466 frs-core:CurrentFinancialInstruments 2024-10-31 15239466 frs-bus:PrivateLimitedCompanyLtd 2023-10-26 2024-10-31 15239466 frs-bus:FilletedAccounts 2023-10-26 2024-10-31 15239466 frs-bus:Micro-entities 2023-10-26 2024-10-31 15239466 frs-bus:AuditExempt-NoAccountantsReport 2023-10-26 2024-10-31 15239466 frs-bus:Director1 2023-10-26 2024-10-31
Registered number: 15239466
Merritt Medical Writing Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2024
Trust Accountancy Advisors Ltd
Balance Sheet
Registered number: 15239466
2024
£
Fixed assets 649
Current assets 13,734
Creditors: Amounts Falling Due Within One Year (6,832 )
NET CURRENT ASSETS 6,902
TOTAL ASSETS LESS CURRENT LIABILITIES 7,551
NET ASSETS 7,551
CAPITAL AND RESERVES 7,551

Notes

1. General Information
Merritt Medical Writing Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15239466 . The registered office is 9 Stockton View, Gainsborough Road, Warrington, WA4 6BJ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Amy-Leigh Merritt
Director
11/04/2025